rdf:type |
|
lifeskim:mentions |
umls-concept:C0009247,
umls-concept:C0012091,
umls-concept:C0017181,
umls-concept:C0019993,
umls-concept:C0027396,
umls-concept:C0030920,
umls-concept:C0032659,
umls-concept:C0035647,
umls-concept:C0068334,
umls-concept:C0210355,
umls-concept:C0332281,
umls-concept:C1527178,
umls-concept:C1705938
|
pubmed:issue |
11
|
pubmed:dateCreated |
2005-11-2
|
pubmed:abstractText |
To identify the unbiased differences in the risk of hospitalization with peptic ulcer disease (PUD) or gastrointestinal (GI) hemorrhage among populations using 4 nonsteroidal antiinflammatory drugs (NSAID): nabumetone, Arthrotec, diclofenac plus a cytoprotective agent dispensed separately (diclo+coRx), and naproxen.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0315-162X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2212-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16265705-Aged,
pubmed-meshheading:16265705-Aged, 80 and over,
pubmed-meshheading:16265705-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:16265705-Butanones,
pubmed-meshheading:16265705-Cohort Studies,
pubmed-meshheading:16265705-Databases, Factual,
pubmed-meshheading:16265705-Diclofenac,
pubmed-meshheading:16265705-Drug Combinations,
pubmed-meshheading:16265705-Female,
pubmed-meshheading:16265705-Gastrointestinal Hemorrhage,
pubmed-meshheading:16265705-Hospitalization,
pubmed-meshheading:16265705-Humans,
pubmed-meshheading:16265705-Male,
pubmed-meshheading:16265705-Middle Aged,
pubmed-meshheading:16265705-Misoprostol,
pubmed-meshheading:16265705-Naproxen,
pubmed-meshheading:16265705-Peptic Ulcer,
pubmed-meshheading:16265705-Risk Factors,
pubmed-meshheading:16265705-Saskatchewan
|
pubmed:year |
2005
|
pubmed:articleTitle |
Risk of hospitalization with peptic ulcer disease or gastrointestinal hemorrhage associated with nabumetone, Arthrotec, diclofenac, and naproxen in a population based cohort study.
|
pubmed:affiliation |
Division of Physical Medicine and Rehabilitation, University of Alberta, Edmonton, Alberta, Canada. ashworth@cha.ab.ca
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|